Course Director, Dr. John Buse, discusses type 2 diabetes in this CME activity titled "An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes." For the full presentation, downloadable practice aids and slides, complete CME information, and to apply for credit, please visit us at PeerView.com/XRN865. CME credit will be available until June 12, 2020.